Fortitude Family Office’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
CC
Fortitude Family Office's DVAX Position: Q4 2025 in Review
Fortitude Family Office sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 1 share — an estimated $10 sold.
Fortitude Family Office first reported a position in DVAX in Q2 2025 and held it in 2 quarters. The position peaked at $30 in Q2 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.
- Fortitude Family Office reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
- Fortitude Family Office sold 1 Dynavax Technologies share in Q4 2025, an estimated $10.
- Fortitude Family Office first reported a position in Dynavax Technologies in Q2 2025 and held it in 2 quarters.
- Fortitude Family Office's Dynavax Technologies position peaked at $30 in Q2 2025.
- 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.
Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.